Profile
Ke Chun Cong is currently a Director at Shandong Zibo Xincat Pharmaceutical Co., Ltd. since 2017.
Formerly, served as a Non-Executive Director at Shandong Xinhua Pharmaceutical Co., Ltd. from 2020 to 2023 and as a Director at Shandong Lukang Pharmaceutical Co., Ltd. from 2009 to 2024.
Education includes graduate and MBA degrees from Zhongnan University of Economics & Law.
Ke Chun Cong active positions
| Companies | Position | Start |
|---|---|---|
Shandong Zibo Xincat Pharmaceutical Co., Ltd.
Shandong Zibo Xincat Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Director/Board Member | 2017-04-15 |
Former positions of Ke Chun Cong
| Companies | Position | End |
|---|---|---|
| SHANDONG LUKANG PHARMACEUTICAL CO.,LTD. | Director/Board Member | 2024-04-22 |
| SHANDONG XINHUA PHARMACEUTICAL COMPANY LIMITED | Director/Board Member | 2023-12-21 |
Training of Ke Chun Cong
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Shandong Xinhua Pharmaceutical Co., Ltd.
Shandong Xinhua Pharmaceutical Co., Ltd. Pharmaceuticals: OtherHealth Technology Develops and sells bulk pharmaceuticals, preparations, & chemical products | Health Technology |
Shandong Lukang Pharmaceutical Co., Ltd.
Shandong Lukang Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceuticals and related biological materials | Health Technology |
Zhongnan University of Economics & Law
Zhongnan University of Economics & Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shandong Zibo Xincat Pharmaceutical Co., Ltd.
Shandong Zibo Xincat Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
- Stock Market
- Insiders
- Ke Chun Cong
















